Program: Scientific Program
Session: Well-Regulated vs Malfunctioning Mechanisms of Iron Metabolism
Hematology Disease Topics & Pathways:
Anemias, sickle cell disease, apoptosis, Diseases, thalassemia, Genetic Disorders, red blood cells, Hemoglobinopathies, Biological Processes, white blood cells, immune cells, Cell Lineage, immune mechanism, inflammation, iron metabolism, iron transport, microenvironment, pathways
Session: Well-Regulated vs Malfunctioning Mechanisms of Iron Metabolism
Hematology Disease Topics & Pathways:
Anemias, sickle cell disease, apoptosis, Diseases, thalassemia, Genetic Disorders, red blood cells, Hemoglobinopathies, Biological Processes, white blood cells, immune cells, Cell Lineage, immune mechanism, inflammation, iron metabolism, iron transport, microenvironment, pathways
Monday, December 7, 2020, 11:25 AM-11:30 AM
Disclosures: Vinchi: Novartis: Research Funding; PharmaNutra: Research Funding; Vifor Pharma: Research Funding; Silence Therapeutics: Membership on an entity's Board of Directors or advisory committees, Research Funding.
See more of: Well-Regulated vs Malfunctioning Mechanisms of Iron Metabolism
See more of: Scientific Program
See more of: Scientific Program